Characteristics of Selectors of Nicotine Replacement Therapy

Overview

Journal Tob Control

Specialty Psychiatry

Date 2005 Sep 27

PMID 16183986

Citations 41

Authors

S Shiffman

M E Di Marino

C T Sweeney

Affiliations

Soon will be listed here.

Abstract

Objective: To assess differences in demographic and smoking characteristics between smokers who have and have not used nicotine replacement therapy (NRT).

Design: Mail survey of US smokers from a national research panel.

Participants: Smokers 18 years and over who returned a survey on smoking (n = 9630). The sample was weighted to match the US smoker population on age and sex.

Main Outcome Measures: Compared smokers who had/had not used NRT in a quit attempt (ever NRT use or over the counter (OTC) NRT use) on: demographic characteristics, nicotine dependence, history of craving and withdrawal, expected difficulty quitting, and self reported history of smoking related medical illness and psychopathology.

Results: NRT users (both ever-users and OTC users) were more likely to be older, male, and better educated. They were also heavier smokers, had experienced more craving and withdrawal upon quitting, and scored higher on measures of dependence. These differences were evident among light smokers, and remained even when smoking rate and time to first cigarette were controlled.

Conclusion: Smokers who elect to use NRT differ from non-NRT users in ways that predispose them to failure in cessation. Controlling for smoking rate and time to first cigarette does not eliminate these differences, even among light smokers. These differences must be considered when comparing the effectiveness of NRT among samples of smokers who self select their treatment and are likely to bias such outcome comparisons.

Citing Articles

Factors Associated with Recent Use of Nicotine Replacement Therapy Among Multiethnic Smokers Residing in Public Housing.

Geller A, Borrelli B, Davine J, Burtner J, Heeren T, Rees V J Smok Cessat. 2024; 13(3):162-170.

PMID: 38911966 PMC: 11193361. DOI: 10.1017/jsc.2017.21.

Predictors of Nicotine Replacement Therapy Adherence: Mixed-Methods Research With a Convergent Parallel Design.

Kim S, Prasad A, Nayak M, Chen H, Srisoem C, DeMarco R Ann Behav Med. 2024; 58(4):275-285.

PMID: 38401531 PMC: 10928836. DOI: 10.1093/abm/kaae006.

A systematic review and meta-analysis of interventions to induce attempts to quit tobacco among adults not ready to quit.

Klemperer E, Streck J, Lindson N, West J, Su A, Hughes J Exp Clin Psychopharmacol. 2022; 31(2):541-559.

PMID: 35771496 PMC: 10106992. DOI: 10.1037/pha0000583.

Government's subsidisation policy and utilisation of smoking cessation treatments: a population-based cross-sectional study in Taiwan.

Wang S, Kao C, Chuang H, Tseng Y, Chen W, Yeh C BMJ Open. 2021; 11(1):e040424.

PMID: 33441354 PMC: 7812102. DOI: 10.1136/bmjopen-2020-040424.

Truck Drivers' Cigarette Smoking and Preferred Smoking Cessation Methods.

Kagabo R, Thiese M, Eden E, Thatcher A, Gonzalez M, Okuyemi K Subst Abuse. 2020; 14:1178221820949262.

PMID: 32848405 PMC: 7427133. DOI: 10.1177/1178221820949262.

References

Nordstrom B, Kinnunen T, Utman C, Krall E, Vokonas P, Garvey A . Predictors of continued smoking over 25 years of follow-up in the normative aging study. Am J Public Health. 2000; 90(3):404-6. PMC: 1446180. DOI: 10.2105/ajph.90.3.404. View

Shiffman S . Nicotine lozenge efficacy in light smokers. Drug Alcohol Depend. 2005; 77(3):311-4. DOI: 10.1016/j.drugalcdep.2004.08.026. View

Burton S, Gitchell J, Shiffman S . Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998. MMWR Morb Mortal Wkly Rep. 2000; 49(29):665-8. View

Lasser K, Boyd J, Woolhandler S, Himmelstein D, McCormick D, Bor D . Smoking and mental illness: A population-based prevalence study. JAMA. 2000; 284(20):2606-10. DOI: 10.1001/jama.284.20.2606. View

Monso E, Campbell J, Tonnesen P, Gustavsson G, Morera J . Sociodemographic predictors of success in smoking intervention. Tob Control. 2001; 10(2):165-9. PMC: 1747562. DOI: 10.1136/tc.10.2.165. View

Shiffman S, Paton S . Individual differences in smoking: gender and nicotine addiction. Nicotine Tob Res. 2002; 1 Suppl 2:S153-7; discussion S165-6. DOI: 10.1080/14622299050011991. View

Rockwood K, Kirkland S, Hogan D, MacKnight C, Merry H, Verreault R . Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol. 2002; 59(2):223-7. DOI: 10.1001/archneur.59.2.223. View

Shiffman S, Dresler C, Hajek P, Gilburt S, Targett D, Strahs K . Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med. 2002; 162(11):1267-76. DOI: 10.1001/archinte.162.11.1267. View

Pierce J, Gilpin E . Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002; 288(10):1260-4. DOI: 10.1001/jama.288.10.1260. View

10.

Hughes J, Shiffman S, Callas P, Zhang J . A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control. 2003; 12(1):21-7. PMC: 1759113. DOI: 10.1136/tc.12.1.21. View

11.

Hughes J, Keely J, Naud S . Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2003; 99(1):29-38. DOI: 10.1111/j.1360-0443.2004.00540.x. View

12.

Ness R, Cauley J . Antibiotics and breast cancer--what's the meaning of this?. JAMA. 2004; 291(7):880-1. DOI: 10.1001/jama.291.7.880. View

13.

Mokdad A, Marks J, Stroup D, Gerberding J . Actual causes of death in the United States, 2000. JAMA. 2004; 291(10):1238-45. DOI: 10.1001/jama.291.10.1238. View

14.

Shiffman S, Waters A, Hickcox M . The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004; 6(2):327-48. DOI: 10.1080/1462220042000202481. View

15.

Pinto R, Abrams D, Monti P, Jacobus S . Nicotine dependence and likelihood of quitting smoking. Addict Behav. 1987; 12(4):371-4. DOI: 10.1016/0306-4603(87)90052-9. View

16.

Heatherton T, Kozlowski L, Frecker R, Rickert W, Robinson J . Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989; 84(7):791-9. DOI: 10.1111/j.1360-0443.1989.tb03059.x. View

17.

Fagerstrom K, Schneider N . Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989; 12(2):159-82. DOI: 10.1007/BF00846549. View

18.

West R, Hajek P, Belcher M . Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med. 1989; 19(4):981-5. DOI: 10.1017/s0033291700005705. View

19.

Glassman A, Helzer J, Covey L, Cottler L, Stetner F, Tipp J . Smoking, smoking cessation, and major depression. JAMA. 1990; 264(12):1546-9. View

20.

Heatherton T, Kozlowski L, Frecker R, Fagerstrom K . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9):1119-27. DOI: 10.1111/j.1360-0443.1991.tb01879.x. View